Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study

Use of plasma DNA to detect mutations has spread widely as a form of liquid biopsy. EGFR T790M has been observed in half of lung cancer patients who have acquired resistance to EGFR tyrosine kinase inhibitors (EGFR‐TKI). Effectiveness of monitoring T790M via plasma DNA during treatment with EGFR‐TKI...

Descripción completa

Detalles Bibliográficos
Autores principales: Sueoka‐Aragane, Naoko, Katakami, Nobuyuki, Satouchi, Miyako, Yokota, Soichiro, Aoe, Keisuke, Iwanaga, Kentaro, Otsuka, Kojiro, Morita, Satoshi, Kimura, Shinya, Negoro, Shunichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768390/
https://www.ncbi.nlm.nih.gov/pubmed/26577492
http://dx.doi.org/10.1111/cas.12847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4768390/
https://www.ncbi.nlm.nih.gov/pubmed/26577492
http://dx.doi.org/10.1111/cas.12847

Ejemplares similares